Tiziana Life Sciences Ltd (NASDAQ:TLSA)
Tiziana Life Sciences Ltd has a live Insider Score.
Scored on 3 qualifying trades from 1 insider in the last 90 days.
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$38.0M
- Net margin
- —
Not enough balance-sheet detail to judge the debt load.
- Total debt
- $932K
- Cash
- $3.2M
Owes more within a year than it holds to pay it.
- Current assets
- $9.4M
- Current liabilities
- $13.6M
- Current ratio
- 0.69
Consumes cash and must keep raising it.
- Operating cash flow
- -$21.7M
- Free cash flow
- -$21.8M
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 127.9M
- Share growth (1y)
- 24.0%
- Cash runway
- 2 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
TLSA Income Statement
| Fiscal Period | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Dec 31, 2025 | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 11.95 M | 0.00 | 9.29 M | 0.00 | 9.29 M |
| Gross Profit | 0.00 | -11.95 M | 0.00 | -9.29 M | 0.00 | -9.29 M |
| SG&A Expense | 0.00 | 0.00 | 5.94 M | 0.00 | 3.93 M | 0.00 |
| R&D Expense | 6.43 M | 0.00 | 3.24 M | 0.00 | 2.58 M | 0.00 |
| Operating Expenses | 11.37 M | 0.00 | 9.19 M | 0.00 | 6.51 M | 0.00 |
| Operating Income | -11.37 M | -11.95 M | -9.19 M | -9.29 M | -6.51 M | -9.29 M |
| Pretax Income | -12.39 M | -12.80 M | -5.63 M | -8.77 M | -7.98 M | -8.63 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | -1.56 M | -3.33 M | 449.00 K |
| Net Income | -12.39 M | -12.80 M | -5.63 M | -7.21 M | -4.65 M | -9.07 M |
| EPS (Basic) | -0.10 | -0.11 | -0.05 | -0.07 | -0.05 | -0.09 |
| EPS (Diluted) | -0.10 | -0.11 | -0.05 | -0.07 | -0.05 | -0.09 |
| Shares Outstanding | 127.87 M | 118.28 M | 116.83 M | 106.67 M | 103.10 M | 102.47 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.